Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

LIGAND PHARMACEUTICALS INCORPORATED Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 5.72 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07

  • LIGAND PHARMACEUTICALS INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 5.72M shares, a 320.37% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 2.58M shares, a 239.16% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 3.54M shares, a 222.20% increase year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 1.36M shares, a 42.05% decline year-over-year.
  • LIGAND PHARMACEUTICALS INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 3.19M shares, a 108.76% increase from fiscal 2024.
  • LIGAND PHARMACEUTICALS INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.53M shares, a 64.88% decline from fiscal 2023.
  • LIGAND PHARMACEUTICALS INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 4.36M shares, a 30.19% decline from fiscal 2022.
  • LIGAND PHARMACEUTICALS INCORPORATED antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 6.24M shares, a 30.21% increase from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-305.72M shares
10-Q · filed 2026-08-07
4.16M shares
10-Q · filed 2026-08-07
2026-03-312.58M shares
10-Q · filed 2026-05-08
2025-12-313.19M shares
10-K · filed 2026-02-27
2025-09-303.54M shares
10-Q · filed 2025-11-07
1.90M shares
10-Q · filed 2025-11-07
2025-06-301.36M shares
10-Q · filed 2026-08-07
1.06M shares
10-Q · filed 2026-08-07
2025-03-31761.00K shares
10-Q · filed 2026-05-08
2024-12-311.53M shares
10-K · filed 2026-02-27
2024-09-301.10M shares
10-Q · filed 2025-11-07
1.81M shares
10-Q · filed 2025-11-07
2024-06-302.35M shares
10-Q · filed 2025-08-08
2.18M shares
10-Q · filed 2025-08-08
2024-03-312.01M shares
10-Q · filed 2025-05-09
2023-12-314.36M shares
10-K · filed 2026-02-27
2023-09-304.76M shares
10-Q · filed 2024-11-08
4.66M shares
10-Q · filed 2024-11-08
2023-06-304.86M shares
10-Q · filed 2024-08-07
4.61M shares
10-Q · filed 2024-08-07
2023-03-314.36M shares
10-Q · filed 2024-05-08
2022-12-316.24M shares
10-K · filed 2025-02-28
2022-09-306.71M shares
10-Q · filed 2023-11-09
6.50M shares
10-Q · filed 2023-11-09
2022-06-306.79M shares
10-Q · filed 2023-08-09
6.40M shares
10-Q · filed 2023-08-09
2022-03-316.00M shares
10-Q · filed 2023-05-08
2021-12-314.79M shares
10-K · filed 2024-02-29
2021-09-305.57M shares
10-Q · filed 2022-11-08
4.98M shares
10-Q · filed 2022-11-08
2021-06-305.09M shares
10-Q · filed 2022-08-09
4.68M shares
10-Q · filed 2022-08-09
2021-03-314.28M shares
10-Q · filed 2022-05-09
2020-12-318.46M shares
10-K · filed 2023-02-28
2020-09-307.03M shares
10-Q · filed 2021-11-09
8.33M shares
10-Q · filed 2021-11-09
2020-06-307.83M shares
10-Q · filed 2021-08-03
8.99M shares
10-Q · filed 2021-08-03
2020-03-3110.14M shares
10-Q · filed 2021-05-06
2019-12-318.93M shares
10-K · filed 2022-02-28
2019-09-3011.55M shares
10-Q · filed 2020-11-06
8.69M shares
10-Q · filed 2020-11-06
2019-06-307.46M shares
10-Q · filed 2020-08-07
7.24M shares
10-Q · filed 2020-08-07
2019-03-317.01M shares
10-Q · filed 2020-05-08
2018-12-312.85M shares
10-K · filed 2021-02-24
2018-09-303.13M shares
10-Q · filed 2019-11-08
3.13M shares
10-Q · filed 2018-11-08
1.79M shares
10-Q · filed 2019-11-08
1.79M shares
10-Q · filed 2018-11-08
2018-06-302.09M shares
10-Q · filed 2019-08-08
2.09M shares
10-Q · filed 2018-08-08
1.12M shares
10-Q · filed 2019-08-08
1.12M shares
10-Q · filed 2018-08-08
2018-03-31148.00K shares
10-Q · filed 2019-05-09
148.40K shares
10-Q · filed 2018-05-09
2017-12-31335.00K shares
10-K · filed 2020-02-27
2017-09-30255.10K shares
10-Q · filed 2018-11-08
2.53M shares
10-Q · filed 2018-11-08
2017-06-303.81M shares
10-Q · filed 2018-08-08
3.76M shares
10-Q · filed 2018-08-08
2017-03-313.71M shares
10-Q · filed 2018-05-09
2016-12-313.54M shares
10-K · filed 2019-02-28
2016-09-303.54M shares
10-Q · filed 2017-11-09
3.52M shares
10-Q · filed 2017-11-09
2016-06-300.00 shares
10-Q · filed 2017-08-09
0.00 shares
10-Q · filed 2017-08-09
2016-03-313.49M shares
10-Q · filed 2017-05-09
3.50M shares
10-Q · filed 2016-05-09
2015-12-313.33M shares
10-K · filed 2018-03-01
3.30M shares
10-K · filed 2016-02-26
2015-09-303.34M shares
10-Q · filed 2016-11-14
3.80M shares
10-Q · filed 2016-11-14
3.30M shares
10-Q · filed 2015-11-09
2015-06-305.30M shares
10-Q · filed 2016-11-14
3.50M shares
10-Q · filed 2015-08-05
2015-03-314.50M shares
10-Q · filed 2016-11-14
2014-12-315.10M shares
10-K · filed 2017-02-28
800.00K shares
10-K · filed 2014-12-01
2014-09-305.00M shares
10-Q · filed 2015-11-09
2014-06-30400.00K shares
10-Q · filed 2015-08-05
2014-03-311.00M shares
10-Q · filed 2015-05-11
2013-12-31800.00K shares
10-K · filed 2016-11-14
2013-09-30900.00K shares
10-Q · filed 2014-10-31
2013-06-301.10M shares
10-Q · filed 2014-08-05
2013-03-311.10M shares
10-Q · filed 2014-05-07
1.20M shares
10-Q · filed 2013-05-08
2012-12-311.10M shares
10-K · filed 2015-02-23
1.90M shares
10-K · filed 2013-03-14
2012-09-301.30M shares
10-Q · filed 2013-11-08
2.00M shares
10-Q · filed 2012-11-14
2012-06-301.30M shares
10-Q · filed 2013-08-01
2.00M shares
10-Q · filed 2012-08-08
2012-03-311.50M shares
10-Q · filed 2013-05-08
2011-12-311.00M shares
10-K/A · filed 2014-12-12
1.60M shares
10-K · filed 2013-03-14
2011-09-301.60M shares
10-Q · filed 2012-11-14
2011-06-301.60M shares
10-Q/A · filed 2012-11-14
2010-12-311.00M shares
10-K · filed 2013-03-14